Arrhythmias & electrophysiologyCohort study

Life expectancy, loss-of-life expectancy, medical expenditures, and trends for atrial fibrillation: A population cohort over 20 years

Heart RhythmPublished

  • retrospective cohort study

Authors' conclusion

AF is associated with substantial LoLE, with the greatest burden observed in younger patients because of their extended lifetime exposure to the condition. Significant outcome improvements between 2011 and 2021 coincide with expanded anticoagulant use and evolving treatment strategies, although the contributions of individual therapeutic advances cannot be isolated in this observational design.

Study context

Population
Patients with incident atrial fibrillation (AF) from Taiwan's National Health Insurance Research Database, 2000 to 2021patients with incident AF
Participants
619,147 patients
Exposure
Loss-of-LE (LoLE) determined by comparison with the matched general population; diagnosis period (2000-2010 vs 2011-2021)

Main finding

As reported in the abstract

LE and LoLE by age group

Life expectancy (LE) and LoLE significantly decreased from the youngest group (age 20-39 years) to the oldest group (age 85-99 years)

P < .001

Observational data: associations, not effects.

Further findings

OutcomeLoLE reduction (years) (95% CI)P value
LoLE reduction, patients aged <65 years (2011-2021 vs 2000-2010) · greatest improvement; reduction in LoLE2.94 (−3.97 to −1.91)P < 0.001

LE and LoLE by sex

Females had longer LE but greater LoLE than males

Mortality rate, youngest subgroup vs matched general population

fold higher mortality rate than the matched general population
19.63

CHA2DS2-VASc score correlation with mortality rate and LE

Correlation with mortality rate
r = 0.988, P < .001
Correlation with LE
r = −0.931, P < .001
Peak LoLE at score 1

Mortality rates, LE, LoLE and medical costs by diagnosis period

Outcomes, including mortality rates, LE, and LoLE, significantly improved in 2011-2021, whereas medical costs increased

Original publication

Life expectancy, loss-of-life expectancy, medical expenditures, and trends for atrial fibrillation: A population cohort over 20 years. Heart Rhythm. Published 2 July 2026. doi:10.1016/j.hrthm.2026.06.035

Summarised from the published abstract; every number is checked against it